Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Before starting any weight loss treatment including lipotropic injections we conduct a thorough health evaluation to ensure that the approach is safe and appropriate for you
Product Name: 5-Amino-1MQ Classification: NNMT Inhibitor / Metabolic Research Compound Structural Description: Small molecule NNMT inhibitor (non-peptide), 5-amino-1-methylquinolinium CAS Number: 685079-15-6 Molecular Weight: 159.21 Da Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: See product label for form details Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
Rotate sites with each injection to prevent lipohypertrophy, which is the buildup of fibrous tissue at repeatedly injected locations
Consent for publication Not applicable
For shots, a common first dose is 1000 mcg daily for a week
